India, Jan. 13 -- ErlySign, the Nagpur-based biotech startup developing India's first salivary biomarker-based screening test for early-stage oral cancer, has announced the appointment of Vishal Kumar as Vice President - Business. The appointment comes as ErlySign prepares for its next stage of expansion and continues to work on making early cancer screening widely accessible.Kumar brings over a decade of experience across Healthcare, Health-tech, and Technology, with a B.Tech from IIT Kharagpur. He is known for his ability to scale business functions and drive organisational transformation. He has led high-impact teams, shaped growth strategies, and built partnerships that strengthen healthcare delivery across diverse ecosystems.Before j...